Australia's most trusted
source of pharma news
Tuesday, 18 June 2024
Tuesday, 18 June 2024
Subscribe
Login
News Headlines
News Headlines
Listen to this story
News
Feud brews over top earner
Posted 27 May 2024 AM
A feud appears to be brewing over market share of Astellas Pharma's top earning drug in Australia, Xtandi, with the pharma warning that it's ready for a battle, if necessary.
This month, Indian generics maker Cipla became the first company to register a generic copy of the prostate cancer treatment, which contains the active enzalutamide, in Australia under four brands - CIP ENZALUTAMID, ENZACIP, ENZALINE, and LUTACIP.
To see the whole article, please login
Posted 27 May 2024 AM
A feud appears to be brewing over market share of Astellas Pharma's top earning drug in Australia, Xtandi, with the pharma warning that it's ready for a battle, if necessary.
This month, Indian generics maker Cipla became the first company to register a generic copy of the prostate cancer treatment, which contains the active enzalutamide, in Australia under four brands - CIP ENZALUTAMID, ENZACIP, ENZALINE, and LUTACIP.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (3)
Sales & Customer Relations (25)
- GP Sales Representative - Sydney
- Hospital Specialist Representative - Sydney
- GP Sales Representative - Brisbane
- GP Sales Representative - Sydney
- Pharmacy Sales Representative - Brisbane
- Pharmacy Sales Representative - Brisbane
- Key Account Manager - Sydney
- Customer Service Representative - Pascoe Vale
- Sales Specialist - Brisbane
- Territory Manager - Perth
- Medical Representative - Melbourne
- Medical Representative - Melbourne
- Sales Executive - Perth
- Key Account Manager - Perth
- Key Account Manager - Brisbane
- Hospital Sales Representative - Sydney
- Hospital Key Account Manager - Queensland
- Hospital Sales Representative - Sydney
- Hospital Key Account Manager - Sydney
- Customer Service Representative - Macquarie Park
- Hospital Specialist Representative - Sydney
- GP Representative - Perth
- Hybrid Representative - Perth
- Commercial Analytics & CRM Specialist - East Ryde
- Customer Service Representative - Westmead
Clinical & Medical, R&D (13)
- QC Analytical Technology Scientist - Dallas
- R&D Project Operations Specialist - Melbourne
- Medical Science Liaison - MSL - Sydney
- Medical Representative - Melbourne
- Medical Science Liaison - Perth
- Medical Representative - Melbourne
- Data Scientist - Sydney
- Medical Science Liaison Lead - Sydney
- Medical Science Liaison - Perth
- Clinical Applications & Technical Support Specialist - Chatswood
- Scientist - Melbourne
- Medical Science Liaison - Melbourne
- Medical Science Liaison - Western Australia
Regulatory, Pharmacovigilance & QA (6)
- Senior Regulatory Affairs Associate - Sydney
- Regulatory Affairs Specialist - Sydney
- Regulatory Affairs Manager - Sydney
- Head of Quality - New South Wales
- Business Quality Lead - North Sydney
- Quality Control Support Analyst - Parkville
Other (17)
- Scheduler & Logistics Coordinator - Brisbane
- Logistic Operator/Forklift Driver - Victoria
- Cardiac Sonographer - Armadale
- Cardiac Sonographer - Tasmania
- Gastroenterologist - Albury
- Storeperson - Toongabbie
- Capability Development Partner - Rhodes
- Loan Kit Technician - Macquarie Park
- Post-Market Manager - North Sydney
- Bookings Officer - West Melbourne
- Loan Kit Scheduler - Brisbane
- Success Coordinator - Melbourne
- MSL Manager - Melbourne
- Analyst - QC Incoming Goods - Dallas
- Warehouse Assistant - Granville
- Analyst - QC Sample Management - Dallas
- Warehouse Assistant - Tullamarine
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.